Ambev Q1: Good Results Confirm The Recommendation

Group 1 - The recommendation to buy Ambev (NYSE: ABEV) shares is reiterated following the release of its first-quarter 2025 results [1] - The article serves as a continuation of the initial coverage published on May 8, 2024, indicating ongoing analysis and insights into the company's performance [1] - The analyst has over 5 years of experience in equity analysis in Latin America, providing in-depth research and insights for informed investment decisions [1]